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Thymus-derived natural Foxp3+ CD4+ regulatory T  cells (nTregs) play a key role in 
maintaining immune tolerance and preventing autoimmune disease. Several studies 
indicate that dendritic cells (DCs) are critically involved in the maintenance and prolif-
eration of nTregs. However, the mechanisms how DCs manage to keep the peripheral 
pool at constant levels remain poorly understood. Here, we describe that the NF-κB/
Rel family transcription factor RelB controls the frequencies of steady-state migratory 
DCs (ssmDCs) in peripheral lymph nodes and their numbers control peripheral nTreg 
homeostasis. DC-specific RelB depletion was investigated in CD11c-Cre  ×  RelBfl/fl 
mice (RelBDCko), which showed normal frequencies of resident DCs in lymph nodes and 
spleen while the subsets of CD103− Langerin− dermal DCs (dDCs) and Langerhans 
cells but not CD103+ Langerin+ dDC of the ssmDCs in skin-draining lymph nodes were 
increased. Enhanced frequencies and proliferation rates were also observed for nTregs 
and a small population of CD4+ CD44high CD25low memory-like T cells (Tml). Interestingly, 
only the Tml but not DCs showed an increase in IL-2-producing capacity in lymph nodes 
of RelBDCko mice. Blocking of IL-2 in vivo reduced the frequency of nTregs but increased 
the Tml frequencies, followed by a recovery of nTregs. Taken together, by employing 
RelBDCko mice with increased frequencies of ssmDCs our data indicate a critical role 
for specific ssmDC subsets for the peripheral nTreg and IL-2+ Tml frequencies during 
homeostasis.
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inTrODUcTiOn
Dendritic cells (DCs) play roles not only in pathogen defense but also for maintaining tolerance 
to self-antigens (1–3). Immature DCs (iDCs) have been shown to exert their tolerogenic proper-
ties by inducing T cell anergy or regulatory T cells (Tregs) in vitro (4, 5). In vivo tolerance may 
be induced by lymph node resident iDCs that capture soluble antigens within the lymph node 
from the reticular conduit system (6). However, to promote antigen-specific tolerance against 
peripheral tissues, DCs must capture self-antigens in peripheral tissues and transport them 
into skin-draining lymph nodes for tolerogenic presentation to T cells (7). In fact, steady-state 
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migratory DCs (ssmDCs) have shown a superior capacity to 
induce Treg in vivo as compared to immature resident subsets 
(8). DC migration in the steady state is accompanied by a 
partial maturation process (semimature) that is distinct from 
pathogen-matured DC by the lack of pro-inflammatory cytokine 
production (9). This concept has recently been confirmed by 
transcriptional profiling (10). Migration of ssmDCs into skin-
draining lymph node T  cell areas requires CCR7 expression 
(11). In the skin, ssmDCs can pick up soluble peptide antigens 
delivered by osmotic minipumps and the subsequent antigen 
presentation in the lymph nodes results in de novo conversion 
of naive T  cells into induced Foxp3+ Tregs (iTregs) (12, 13). 
Using a murine transgenic model expressing OVA as a neo-
self-antigen in the epidermis (K5-mOVA) we showed that also 
tissue-associated antigens are carried by ssmDCs, which are 
then cross-presented resulting in CD8+ T cell deletion (14) or 
de novo conversion of naive CD4+ T  cells into Foxp3+ Tregs 
(15). In addition, we could show that the alternative NF-κB 
signaling pathway through RelB/p52 in regulating the function 
of Langerin+ dermal DCs (dDC) subset among the ssmDCs 
was critically involved in iTreg conversion (15). The functional 
importance of Treg induction by ssmDCs has been shown by 
their role in the protection from autoimmunity (8).
Members of the NF-κB family such as RelA, RelB, and c-Rel 
have mostly been associated with inflammation or immuno-
genicity for many cell types (16) including DCs (17). However, 
the functional role of this molecule in tolerogenic DCs is not 
fully understood since homozygous RelB−/− mice lack peripheral 
lymph nodes (18), which do not allow us to study ssmDCs, and 
the results we obtained from heterozygous RelB+/− (15) mice 
may involve indirect effects from other cell types. Therefore, 
we investigated the role of RelB in ssmDCs in more detail 
and the consequences for Treg induction. To address this we 
used mice expressing the Cre-recombinase under the murine 
CD11c promoter (CD11c-Cre mice) (19), which were crossed 
with mice where both alleles of the RelB gene were flanked by 
lox P sites (RelBfl/fl mice). The resulting RelBDCko mice allowed 
deeper molecular insights in Treg generation and maintenance 
in peripheral lymph nodes.
MaTerials anD MeThODs
Mice
CD11cCRE mice express the Cre-recombinase under the 
CD11c promoter (19). In RelBfl/fl mice, the exon 4 of the relB 
gene is flanked by loxP sites (20). RelBfl/fl mice were mated 
with CD11cCRE mice to investigate the effects of a conditional 
deletion of RelB in DCs. Resulting CD11cCRE × RelBfl/fl (subse-
quently referred to as RelBDCko) mice and corresponding control 
mice (RelBfl/fl or CD11cCRE) were used at 5–12 weeks of age, if 
not otherwise indicated. C57BL/6 mice were purchased from 
Charles River (Sulzfeld, Germany) and bred in our respective 
facilities. OT-II mice were kindly provided by Francis Carbone, 
Melbourne, Australia and were crossed for some experiments 
with RAG1−/− mice (gift from Thomas Winkler, University of 
Erlangen, Germany). Animal care, housing, and all experiments 
were performed according to institutional guidelines by the 
Animal Ethics Committee of the local authorities in Würzburg, 
Jena and New York, with age- and sex-matched animals.
cell Preparation
Skin-draining lymph nodes (inguinal, axillary, brachial, and 
popliteal), spleens, and thymi were cut into small pieces by using 
forceps and digested for 20  min at RT with 1  mg/ml DNase I 
(Roche) and 1  mg/ml collagenase III (Worthington) in RPMI 
1640 medium supplemented with 10% FCS, 2 mM l-glutamine 
(PAA), 100 U/ml penicillin (PAA), and 100 µg/ml streptomycin 
(PAA). To disrupt multicellular complexes that include DC and 
T  cells, 0.01  mM EDTA (Sigma) was added and incubation at 
RT was extended for 5 min. Cells were resuspended in ice cold 
PBS containing 5% FCS and 1 mM EDTA, transferred through a 
70 µm cell strainer (BD) and counted. Splenic cells were addition-
ally subjected to erythrocyte lysis before enzymatic digestion. 
BM-DC were prepared as described in detail before (21).
antibodies and Flow cytometry
For cell surface staining the following monoclonal antibod-
ies (mAbs) and conjugates from Biolegend were used: B220 
(clone RA3-6B2), CD4 (clone RM4-5 and GK1.5), CD8α (clone 
53-6.7), CD11c (clone N418), CD25 (clone PC61 and 7D4), 
CD40 (clone 3/23), CD80 (clone 16-10A1), CD86 (clone GL-1), 
CD103 (clone M290), GITR (clone DTA-1), MHC II (clone 2G9 
and M5/114.15.2), PD-1 (clone J43), and PDCA-1 (clone 927). 
Antibodies for CD44 (clone IM7) and Vβ5.1/5.2 (clone MR9-4) 
were purchased from BD. If primary antibodies were biotinylated, 
the following secondary antibodies were used: streptavidin–
FITC, –PE, –PECy7 (Biolegend), or streptavidin–Pacific Blue 
(Invitrogen).
Intracellular staining of Foxp3 (clone FJK-16s, eBiosciences), 
Helios (clone 22F4, Biolegend), and Ki67 (clone B56, BD) was 
performed in accordance with the manufacturer’s protocol of the 
Anti-Mouse Foxp3 Staining Set (eBiosciences). Flow cytometric 
staining of RelB was done by using first a polyclonal rabbit 
anti-mouse RelB antibody (C-19, Santa Cruz) followed by a goat 
anti-rabbit-DyLight488 antibody (Jackson) as described previ-
ously (15). For detection of intracellular Langerin, cells were fixed 
and permeabilized in Cytofix/Cytoperm (BD) for 20 min at RT, 
washed in Perm/Wash Buffer (BD), and incubated with a rat anti-
mouse Langerin-AlexaFluor488 (clone 929F3.01, Dendritics) for 
30 min at 4°C.
All flow cytometric analyses were performed on a FACS-
Calibur, FACSCanto II, or LSRII (BD) and data were analyzed by 
FlowJo Software (Tree Star).
Ex Vivo stimulation and cytokine staining 
of cells from lymph nodes
Single cell suspensions from skin-draining lymph nodes were 
prepared as described above and resuspended at a density 
of 4 ×  106 cells per ml in complete RPMI 1640 medium. Cells 
were then stimulated with 10 ng/ml PMA (Sigma) and 1 µg/ml 
ionomycin (Sigma) in the presence of 5  µg/ml brefeldin A 
(Sigma) for 5 h at 37°C. After stimulation, cells were stained for 
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surface markers (CD4, CD11c, CD25, and CD44), fixed in 2% 
formaldehyde for 20 min at RT, and stained intracellularly with 
an IL-2 specific antibody (clone JES6-5H4, Biolegend) in Perm 
Buffer (PBS supplemented with 0.5% saponin, 0.1% BSA, and 
0.05% sodium azide) for 30  min at 4°C. Control straining was 
performed with a PE-conjugated rat IgG2b isotype.
implantation of Micro-osmotic Pumps 
secreting OVa327-339 Peptide
Micro-osmotic pumps (ALZET, model 1002, Charles River) 
were filled with PBS or OVA327-339 peptide, respectively, to deliver 
10 µg antigen per day as described previously (12). To decrease 
the start-up time for continuous and reliable pumping, prefilled 
micro-osmotic pumps were placed in PBS for at least 6 h at 37°C 
before implantation. For subcutaneous implantation, a small 
incision was made on the back next to the hips, a subcutaneous 
pocket was formed, and the pump was inserted. The wound was 
closed by saturation and using AutoClip Wound Closure System 
(Charles River). Adoptive transfer of T cell was carried out 1 day 
after implantation.
adoptive Transfer of T cells from WT and 
OT-ii Mice
Single cell suspensions of lymph nodes (pooled skin-draining 
and mesenteric lymph nodes) and spleens from WT, OT-II, and 
OT-II.Rag1−/− mice were prepared as described above. CD4+ 
T  cells were purified by negative magnetic separation using 
either the Mouse CD4 T Cell Enrichment Kit (StemCell) or the 
Mouse CD4+ T Cell Isolation Kit II (Miltenyi Biotec) according 
to the manufacturer’s instructions. For further isolation of CD25+ 
CD4+ T  cells from WT and OT-II mice a positive magnetic 
separation was performed using Mouse CD25 Micro Beads 
(Miltenyi Biotec) in accordance to the recommendations of the 
manufacturer. The purity of the isolated T cell populations was 
assessed by flow cytometry (CD4+ > 90%, CD4+ CD25+ > 60%). 
For labeling with carboxyfluorescein diacetate succinimidyl ester 
(CFSE) cells were resuspended at a density of 1 × 107 cells per ml 
in PBS containing 2.5 µM CFSE (Molecular Probes, Invitrogen) 
for 15 min at RT. Subsequently, cells were washed with complete 
RPMI 1640 medium, resuspended in an appropriate volume of 
PBS, and injected into the lateral tail vein of recipient mice. After 
the indicated time points recipient mice were sacrificed and cell 
suspensions from skin-draining lymph nodes and spleens were 
prepared. Cells were stained with antibodies for CD4 and Foxp3 
and analyzed by flow cytometry.
Treatment with anti-il-2 antibody
To neutralize IL-2, mice received intraperitoneally 2  mg anti-
IL-2 mAb (clone S4B6, BioXCell). Before injection and at the 
indicated time points after injection blood was taken from 
submandibular vein, stained for CD4, Foxp3, and Ki67, and 
analyzed by flow cytometry.
rna isolation and qrT-Pcr
Total RNA was isolated from sorted T cells and DC using Micro 
Rneasy Kit (Qiagen) according to manufacturer’s instructions. 
mRNA was amplified (Nano or Pico AmpTec Express Art Kit), 
digested with DNAse I (MBI Fermentas), and reverse transcribed 
using iScript (Biorad) in accordance to the recommendations of 
the manufacturer. Quantitative expression analysis of IL-2, IL-7, 
IL-15, and RelB was determined with a iCycler iQ (Biorad) using 
the following primers: mIL-2-FOR TTTGAGTGCCAATTCG 
ATGA, mIL-2-REV AGGGCTTGTTGAGATGATGC, mIL-7- 
FOR2 TC AGCATCGATGAATTGGAC, mIL-7-REV2 CCAGT 
GTTTGTGTGCCTTGT, mIL-15-FOR CATTTTGGGCTGTG 
TCAGTG, mIL-15-REV TGCAACTGGGATGAAAGTCA, 
RT-RelB-F CCGAGCTAGGGGCCTTGGGTTCC, and RT- 
RelB-R AGCTCGATGGCGGGCAGGGTCTTG. qRT-PCR was 
performed in 25 µl SYBR Green Master mix (MBI Fermentas) 
containing 1 µl cDNA (undiluted or 1:10 diluted) and 0.2 µM 
of forward and reverse primers. The PCR program was: 
95°C for 14 min and then 40 cycles of 95°C for 30 s, 60°C for 
30  s, and 72°C for 30  s followed by a melting curve analysis. 
Relative quantification of the samples was performed by the 
comparative ΔΔ cycle threshold method. For normalization 
of the samples the housekeeping gene β-actin (β-Actin-F 
QRT CATTGCTGACAGGATGCAGA, β-Actin-R QRT TTG 
CTGATCCACATCTGCTG) was used.
immunofluorescence and confocal 
Microscopy
To detect and calculate DC in skin, immunofluorescence stain-
ings of MHC II+ cells were performed using either epidermal 
sheets or frozen cryostat sections of ear skin. Epidermal sheets 
were prepared as described previously (22). Briefly, ears were 
washed in 70% ethanol and dried at RT. Ventral and dorsal 
sides of each ear were separated with fine forceps and the sides 
with dermis down were floated on 0.5 M ammonium thiocy-
anate for 25  min at 37°C. Sides were washed with PBS, and 
the epidermis was peeled off the dermis, cut into small pieces, 
and fixed for 20 min with acetone at RT. After several wash-
ing steps (2× PBS, 2× 1% BSA/PBS), epidermal sheets were 
incubated with 10% BSA/PBS for 30 min to block unspecific 
binding of antibodies, stained with a pure rat anti-mouse MHC 
II (clone 2G9, BD) or a rat IgG2a isotype (BD) overnight at 
4°C followed by a donkey anti-rat IgG F(ab′)2-AlexaFluor488 
(Jackson) for 30 min at RT. Immunolabeled epidermal sheets 
were mounted in Vectashield Mounting Medium (Vector 
Laboratories) and viewed on a fluorescence microscope (DM 
IRE220, Leica). Skin cryostat sections (9 µm) were fixed with 
ice cold acetone for 15 min, dried for 30 min, and rehydrated 
in PBS followed by blocking in 10% BSA/PBS for 30 min at RT. 
Immunofluorescence staining and microscopically imaging 
of MHC II+ cells were performed as described for epidermal 
sheets.
statistics
Statistical analyses were performed using Prism 5.0 software 
(GraphPad Prism). The unpaired, two-tailed Student’s t-test 
was used, if data sets of two independent groups were normally 
distributed. The Mann–Whitney test was performed when data 
sets of two groups were not normally distributed.
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resUlTs
relBDcko Mice show increased ssmDc 
Frequencies in Peripheral ln (Pln)
Previously, we could show in RelB+/− mice that ssmDCs of skin-
draining PLN expressed the highest levels of RelB under steady-
state conditions (15). Here, we tested whether DC-intrinsic 
dele tion of RelB in RelBDCko mice affected the ssmDC populations 
in PLNs. Intracellular FACS analysis of DCs from thymus, periph-
eral lymph nodes, and spleen confirmed highest RelB expression 
in PLNs and this could not be detected in RelBDCko mice (Figures 
S1A,B in Supplementary Material), while similar levels of surface 
MHC II and CD80/CD86 costimulatory molecules were detected 
(Figures S2A,B in Supplementary Material). Further analyses of 
PLN DC indicated that the CD11c+ CD40high ssmDCs but not 
the CD11c+ CD40low resident DCs were increased in RelBDCko 
mice (Figures  1A,B), while the total lymph node and spleen 
cell numbers remained unchanged (Figure S3 in Supplementary 
Material). In addition, also the skin distribution and frequency of 
DCs remained unaltered (Figure S4 in Supplementary Material). 
The ssmDCs in PLN homogenously express RelB (Figures 
S1C,D in Supplementary Material) and consist of three major 
subsets composed of Langerin+ CD103− epidermal Langerhans 
cells (LCs), Langerin+ CD103+ dDCs, and Langerin− CD103− 
dDCs (Figure  1C) (23). When these ssmDCs were analyzed, 
we found increased proportions of LCs and Langerin− dDCs, 
while Langerin+ dDCs remained unchanged in RelBDCko mice 
(Figure 1D). Increased frequencies of DC subsets may result from 
enhanced proliferation or reduced apoptosis. However, ssmDCs 
did not show altered proliferation rates as detected by Ki67 stain ing 
(Figure S5A in Supplementary Material) or changes in Annexin 
V binding as a sign of apoptosis (Figure S5B in Supplementary 
Material). Thus, the reason for the selective increase in some but 
not all ssmDC subsets remains open.
relBDcko Mice show increased 
Frequencies of Proliferating Tregs in Plns
Since we showed before that Langerin+ dDCs were the decisive 
subset of ssmDCs in PLNs that converted naive CD4+ T cells into 
Foxp3+ Tregs (15), we analyzed the Treg population of RelBDCko 
mice. Frequencies and absolute numbers of CD4+ Foxp3+ Tregs 
were increased in PLNs of RelBDCko mice, while CD4+ Foxp3− 
conventional T cells (Tconv) were decreased (Figure 2A). This 
was not observed for total CD4+ or CD8+ T  cells or B  cells in 
PLNs or spleen (Figure S6 in Supplementary Material). The CD4+ 
Foxp3+ Tregs of RelBDCko mice showed an activated phenotype 
by expressing significantly higher levels of PD-1 and Helios, 
while no or only trends of higher CD25, CD69, CD44, and GITR 
surface expression levels could be observed (Figure 2B). In addi-
tion, these activated Tregs also showed higher proliferation rates 
as indicated by elevated Ki67 expression (Figures 2C,D).
In order to test whether increased Treg frequencies could be a 
result of enhanced thymic output, the thymocyte frequencies of 
these mice were analyzed. The data indicate that already in the 
thymus CD4+ CD8− Foxp3+ T cells appeared at a higher frequency 
and were proliferating whereas other thymocyte populations 
remained normal (Figures S7A–E in Supplementary Material). 
These data indicate that the frequency of proliferating nTregs is 
increased in thymus and PLNs of RelBDCko mice.
Decreased iTreg conversion Potential but 
expansion of nTregs in relBDcko Mice
Although the results may point to the thymic output as the 
res ponsible mechanism for a higher Treg frequency observed 
in spleen and lymph nodes, these data cannot explain the 
continuation of proliferation of Tregs in the PLN and spleen. 
Furthermore, it remained unclear whether the Treg increase 
was due to enhanced iTreg generation or expansion of nTregs 
and whether the effects depend on self-antigen. To clarify these 
points adoptive transfer experiments were performed using 
T  cells from naive CD4+ OT-II  ×  RAG1−/− mice. These mice 
lack both the endogenous repertoire of T cells and CD4+ Foxp3+ 
transgenic OT-II Tregs. Thus, the transferred cells constituted 
exclusively of naive CD4+ Foxp3− transgenic OT-II T cells and 
the appearance of CD4+ Foxp3+ transgenic OT-II Tregs cells 
would indicate de novo conversion of naive CD4+ OT-II T cells 
into iTregs. After transfer of naive CD4+ OT-II × RAG1−/− T cells 
into control or RelBDCko mice OVA-loaded osmotic minipumps 
were implanted under the skin as a source of soluble peripheral 
self-antigen (15). The results showed a lower antigen-specific 
iTreg conversion into CD4+ Foxp3+ Tregs (Figures  3A,B) and 
Tconv a trend for an increased proliferation rate in RelBDCko mice 
(Figure 3C). Importantly, de novo conversion of naive T cells into 
iTregs is not increased in RelBDCko mice.
Conversely, adoptively transferred thymus-derived nTregs can 
be tested for their antigen-dependent expansion in peripheral 
lymph nodes. To distinguish whether only self-antigen-specific 
nTreg can be stimulated in lymph nodes or also nTreg with foreign 
antigen specificity we used two different settings of nTreg transfer. 
In naive Wt mice, the CD4+ CD25+ nTregs are predominantly 
specific for self-antigens (24). After transfer of self-antigen-
specific nTregs we detected their enhanced proliferation in PLN 
of RelBDCko but not control mice or the spleen (Figure 4A). Since 
this increased nTreg proliferation correlated with increased fre-
quencies of self-antigen transporting LCs and CD103− Langerin− 
dDCs we hypothesized that antigen presentation of these two DC 
subsets may play a role.
In the second setting, we transferred nTregs from OT-II 
mice that are specific for foreign OVA antigen and express a 
high affinity TCR, since OVA is not expressed in the thymus of 
OT-II mice. Then PBS- or OVA-loaded minipumps as a source 
of antigen were provided. Here, an increased expansion of CD4+ 
CD25+ nTregs from OT-II mice could be observed in mice car-
rying OVA-pumps, indicating a supporting role of antigen for 
nTreg proliferation (Figure  4B). However, a higher expansion 
rate of nTregs in RelBDCko mice than in control mice could not 
be observed after the implantation of OVA-loaded minipumps 
(Figure 4B). The results above (Figure 3) and our previous find-
ings showed that the Langerin+ dDCs were responsible for OVA 
transport and presentation as well as de novo conversion of iTregs 
(15). These results are consistent with the fact that in PLNs of 
RelBDCko mice with the frequency of CD103+ Langerin+ dDC was 
not increased also the iTreg conversion rate was not enhanced. 
FigUre 1 | RelBDCko mice show an increased frequency of Langerhans cells (LCs) and Langerin− dermal DCs (dDCs) among steady-state migratory DCs in 
skin-draining lymph nodes. (a,B) Cells from peripheral LN (PLN) of control and RelBDCko mice were stained for B220, CD11c, and CD40 and analyzed by flow 
cytometry. (a) Contour plots represent CD11c+ B220− cells within a FSC/SSC gate for live cells. Based on the expression of CD40 migratory CD40hi dendritic cell 
(DC) and resident CD40low DC are distinguished among CD11c+ B220− cells. B220− CD11clow CD40low cells represent RelB− macrophages. Numbers indicate the 
percentages of cells within the gate. (B) Statistical summary of frequencies of migratory and resident DC among CD11c+ B220− cells PLN of RelBDCko (n = 11) or 
control mice (n = 7). Percentages of both DC subsets among CD11c+ B220− cells were calculated in relation to the absolute frequency of CD11c+ B220− cells. Each 
symbol represents an individual mouse and black lines indicate the mean values. Statistical analyses were performed using the Mann–Whitney Test: ns, not 
significant, *p < 0.05. (c) Representative flow cytometric analysis of migratory DC subpopulation in PLN of control and RelBDCko mice after surface staining of 
CD11c, CD40, and CD103 and intracellular staining of Langerin. After gating specifically on CD11c+ B220− cells (right panel), migratory CD40hi DCs (middle panel) 
were further analyzed for their expression of Langerin versus CD103. Three migratory DC subsets could be defined: Langerin+ CD103− LC, Langerin+ CD103+ dDC, 
and Langerin− CD103+/− dDC (left panel). Numbers indicate the percentages of cells within each gate. (D) Frequencies of Langerin+ CD103− LC, Langerin+ CD103+ 
dDC, and Langerin− CD103+/− dDC among the total percentages of CD40hi CD11c+ B220− cells in PLN of control (n = 7) and RelBDCko mice (n = 7) are shown. Data 
represent the mean values + SD from two independent experiments with 3–4 mice per genotype and each experiment. Statistical p-values were obtained by 
performing two-tailed unpaired Student’s t-test: ns, not significant, *p < 0.05, **p < 0.01.
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In contrast, increased frequencies of CD103− Langerin− dDCs 
and LCs in PLNs of RelBDCko mice correlated with an enhanced 
proliferation rate of nTreg. These data may indicate a division of 
labor among ssmDC subsets from the skin for iTreg conversion 
by CD103+ Langerin+ dDCs and nTreg stimulation by CD103− 
Langerin− dDCs and/or LCs. Although the role of LCs cannot 
FigUre 2 | Continued
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FigUre 3 | RelBDCko mice do not promote enhanced induction of iTregs. (a) Scheme of experimental setup. Micro-osmotic pumps loaded with PBS or OVA peptide 
were subcutaneously implanted in RelBDCko and control mice. One day later mice received an intravenous injection of 4.5–5 × 106 carboxyfluorescein diacetate 
succinimidyl ester (CFSE)-labeled CD4+ CD25− OT-II × Rag1−/− T cells. Twelve days after adoptive transfer, cell suspensions from peripheral LN (PLN) and SPL of 
RelBDCko and control mice were stained for CD4 and Foxp3 and analyzed by flow cytometry. (B) Representative dot plots showing CFSE and Foxp3 expressing 
among transferred CFSE+ CD4+ T cells in PLN and SPL. Numbers indicate percentages of cells in each quadrant. (c) Percentages of Foxp3+ iTregs among CFSE+ 
CD4+ T cells in PLN and SPL of RelBDCko (n ≥ 6) and control mice (n ≥ 5) are depicted. (D) Frequencies of proliferating CFSElow Foxp3− conventional T cells among 
CFSE+ CD4+ Foxp3− T cells in PLN and SPL of RelBDCko (n ≥ 6) and control mice (n ≥ 5). (B–D) Data represent the mean values + SD from three independent 
experiments with n ≥ 2 mice per genotype and condition. Statistical analyses were performed using Mann–Whitney test: ns, not significant, p < 0.05.
FigUre 2 | Continued  
Mice with a RelB deficiency in dendritic cell display an increased frequency of proliferating Foxp3+ regulatory T cells (Tregs). (a) Cells from peripheral LN (PLN) and 
SPL of control and RelBDCko mice were analyzed by flow cytometry for surface CD4 and intracellular Foxp3 expression. Percentages and absolute numbers of Foxp3+ 
Treg and Foxp3− conventional T cells (Tconv) among CD4+ T cells in peripheral lymphoid organs of control mice (n ≥ 7) and RelBDCko mice (n = 7) are shown.  
(B) Geometric MFI of CD25, CD44, CD69, PD-1, Helios, and GITR expression by CD4+ Foxp3+ Treg in PLN and SPL of control mice (n ≥ 3) and RelBDCko mice 
(n ≥ 3) are displayed. (c,D) Cells from PLN and SPL of control and RelBDCko mice were analyzed by flow cytometry for surface CD4 and intracellular Foxp3 and Ki67 
expression. (c) Representative dot plots showing Ki67 and Foxp3 expression among CD4+ T cells. Numbers indicate the percentages of cells in each quadrant.  
(D) Percentages of proliferating Ki67+ Foxp3+ Treg and Ki67+ Foxp3− Tconv among CD4+ T cells in PLN and SPL of control mice (n = 8) and RelBDCko mice (n = 6) are 
shown. (a,B,D) Data represent the mean values + SD. Mann–Whitney test was used for statistical analyses: ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001.
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FigUre 4 | Expansion of self-antigen-specific Foxp3+ nTregs in peripheral lymph nodes of RelBDCko mice. (a) Carboxyfluorescein diacetate succinimidyl ester 
(CFSE)-labeled CD4+ CD25+ T cells (3 × 106) from wild-type mice were intravenously transferred into RelBDCko and control mice. Eight days later cell suspensions 
from peripheral LN and SPL were stained for CD4 and Foxp3 and analyzed by flow cytometry. Graphs display the percentages of proliferating (CFSElow) cells among 
CFSE+ CD4+ Foxp3+ T cells (right) as mean value + SD. Data shown are representative of two independent experiments with one mouse per genotype in each 
experiment. (B) PBS- or OVA peptide-loaded osmotic minipumps were subcutaneously implanted in RelBDCko and control mice. One day later mice received an 
intravenous injection of 1.4 × 106 CFSE-labeled CD4+ CD25+ OT-II T cells. For flow cytometric analysis, mice were sacrificed 5 days after adoptive transfer and 
stained for CD4 and Foxp3. Graphs display the percentages of proliferating CFSElow cells among all transferred CFSE+ CD4+ Foxp3+ nTregs. Data represent the 
mean values + SD from one representative experiment with n = 2–5 mice per genotype and condition. (a,B) Statistical analyses were performed using unpaired 
student’s t-test: ns, not significant, *p < 0.05.
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be clearly deducted from our experiments, others have shown 
that resting LCs in the epidermis stimulate skin resident Treg 
activation and proliferation (25) and that glucocorticoids further 
promote TGF-β production by LCs to enhance Treg numbers in 
contact hypersensitivity patients (26).
Together, these data obtained from RelBDCko mice indicate 
that beyond the thymic selection also self-antigen presentation 
by Langerin− dDCs and/or LCs in PLNs regulates the pool of 
self-antigen-specific nTregs.
cD4+ cD44high cD25low Memory-like  
T cells (Tml) show increased il-2 
Production in steady-state Plns  
of relBDcko Mice
During the steady state, the niche size for nTreg in the thymus 
is controlled by the availability of IL-2 provided by DCs (27). 
Also, peripheral maintenance of nTregs is dependent on IL-2 
(28, 29), which is secreted from presumably self-reactive CD4+ 
CD25low non-Tregs (30). Here, we sought to identify the source 
of increased IL-2-competent cells in PLNs by real-time PCR and 
FACS analyses in RelBDCko mice. Total PLN cells were stimulated 
with PMA + ionomycin and the only IL-2 producing cells were 
identified as CD11c+ DC (Figures  5A,B) and CD4+ CD25low 
CD44high Tml (Figures 5C,D). An increase in the frequency of 
IL-2 producing cells in RelBDCko mice was observed only for the 
Tml but not the DCs (Figures 5A–D) together with the total 
frequency of CD4+ CD44high T cells in PLNs of RelBDCko mice 
(Figure  5E). These data suggest that IL-2+ Tml and not DCs 
may contribute to the elevated Treg proliferation in RelBDCko 
mice. To substantiate the results, we sorted the ssmDC popula-
tions from PLN of RelBDCko and control mice and tested their 
IL-2, IL-7, and IL-15 production at real-time PCR level. These 
data indicate that IL-2 is not produced by DCs in PLNs and no 
differences were found for the other cytokines between RelBDCko 
and control mice (Figure  5F). To demonstrate that IL-2 is 
FigUre 5 | IL-2 produced by CD4+ CD25int CD44hi T cells is required for regulatory T cell (Treg) maintenance in RelBDCko mice. (a–D) Single cell suspensions from 
peripheral LN (PLN) of control and RelBDCko mice were either left unstimulated or activated with PMA/ionomycin for 5 h in the presence of brefeldin A. After 
incubation cells were stained (surface: CD11c, CD4, and CD44; intracellular: IL-2) and analyzed by flow cytometry. (a) Representative dot plots showing expression 
of CD11c and IL-2 among CD11c+ dendritic cell (DC). Numbers in each quadrant indicate the percentages of cells gated on CD11c+ cells. (B) Graphs display the 
percentages of IL-2+ CD11c+ DC among CD11c+ DC compiled from five independent experiments with one mouse per genotype and condition in each experiment. 
(c) Representative dot plots showing expression of CD44 and IL-2 among CD4+ T cells. Numbers in the quadrants indicate the percentages of cells gated on CD4+ 
cells. (D) Compiled date from percentages of IL-2+ CD44+ cells among CD4+ T cells of five independent experiments with one mouse per genotype and condition in 
each experiment are displayed. (e) Percentages of CD25int CD44hi cells among CD4+ T cells in PLN of control (n = 6) and RelBDCko mice (n = 7) from five 
independent experiments are shown. (F) mRNA expression of IL-2, IL-7, and IL-15 in sorted migratory CD40hi DC from PLN of control and RelBDCko mice analyzed 
by qRT-PCR. (g) Injection of an IL-2 neutralizing antibody abrogated Treg but not conventional T cells (Tconv) cell division in RelBDCko mice. 1 mg αIL-2 antibody 
was injected intraperitoneal into RelBDCko and control mice. Before injection and 2, 4, 7, 14, and 21 days afterward blood samples were taken, stained for CD4, 
CD44, Foxp3, and Ki67, and analyzed by flow cytometry. Kinetics of the percentages of proliferating CD4+ Ki67+ Foxp3− Tconv, CD4+ Ki67+ Foxp3+ Tregs, and 
CD4+ CD44high Foxp3− memory-like T cells after αIL-2 injection are shown in the diagram. Three mice per genotype and experiment were used. Depicted is one 
representative experiment from four experiments. (B,D,e,F) Data represent the mean values + SD. For statistical analyses student’s t-test was performed: ns, not 
significant, *p < 0.05.
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functionally required for Treg proliferation in the RelBDCko 
mice we injected a blocking anti-IL-2 antibody (clone S4B6) 
and found that proliferating Ki67+ CD4+ Foxp3+ Treg but not 
Ki67+ CD4+ Foxp3− Tconv frequencies in blood dropped with 
a maximum between day 4 and 7 after injection and recovered 
thereafter (Figure  5G). In contrast to Treg and Tconv, Tml 
frequencies increased at days 4 and 7. Thus, the CD4+ Tml 
population in RelBDCko mice is not only increased in their 
cellular frequency but also the proportion of IL-2 producers 
among them is elevated as compared to control mice, thereby 
enabling higher nTreg proliferation and pool sizes in PLNs of 
RelBDCko mice.
DiscUssiOn
Here, we investigated the cellular composition of lymphoid 
organs in mice deficient for RelB expression in CD11c+ DCs 
under steady-state conditions, termed RelBDCko mice. The results 
indicate an increased frequency of epidermal LCs and CD103− 
Langerin− dDCs in the PLNs of RelBDCko mice as compared 
with control mice. We could not answer the question how RelB 
controls the frequency of these ssmDC subsets in RelBDCko mice. 
Their distribution in the skin and their apoptosis rate in PLNs 
appeared normal. However, RelB could influence the expression 
of maturation markers and chemokine receptors differentially. 
After contact sensitivity responses it was found that LCs and 
dDCs display differences in activation markers and homing (31). 
The production of CCL17 by ssmDCs in lymph nodes is restricted 
to CD11+ CD8− DC subsets (32) and its secretion further impacts 
migration patterns by other DCs by controlling their responsive-
ness to CCR7 ligands and CXCL12 (33). Thus, further analyses 
on the functional consequences of RelB deficiency in DCs are 
needed.
Further analysis of cellular subsets in PLNs of RelBDCko mice 
indicated changes in the frequencies of specific T cell subsets. 
The increase of the two ssmDC subsets was accompanied by 
increased frequencies of CD4+ CD25+ Foxp3+ nTregs and CD4+ 
CD25low CD44high Tml. Tml have been shown before to represent 
the responsible T cell subset in the steady state that provides IL-2 
for nTreg proliferation and maintenance, required to prevent 
autoimmunity (30). Tml represent a small proportion of CD4+ 
Tconv with low-affinity TCRs for self-antigen that escape the 
thymic negative selection (34). In the thymus, Tregs recognize 
IL-2 derived from DCs that seems to regulate the thymic Treg 
pool size (27). In the periphery, steady-state presentation of 
self-antigens together with IL-2 production has been demon-
strated to be the critical components for nTreg survival (28). 
Treg and IL-2+ Tml locate in close proximity in lymph nodes 
(35). Here, we found that increased frequencies of ssmDCs 
are accompanied by increased proliferation rates of only two 
other populations, namely nTregs and IL-2+ Tml. DC-mediated 
self-antigen presentation may stimulate Tml to release IL-2 that 
supports nTreg steady-state proliferation and maintenance (35). 
The requirement for self-antigen presentation is supported by 
our findings that adoptively transferred self-antigen-specific 
WT nTregs but not foreign antigen-specific OT-II nTreg were 
specifically boosted in their proliferation in PLNs of RelBDCko 
mice but not in control mice or in the spleen. Thus, autoreactive 
Tml stimulated by self-antigen-presenting ssmDCs may respond 
by secreting IL-2 for nTreg proliferation and thereby help to 
control the peripheral nTreg pool size.
Besides IL-2 nTreg may require a TCR signal for proliferation. 
nTregs in RelBDCko mice are also expressing higher levels of acti-
vation markers PD-1 and HELIOS and the proliferation marker 
Ki67, indicating a recent encounter of their TCR. Since the func-
tional task of all ssmDC subsets is self-antigen transport from 
peripheral tissues such as the skin into draining lymph nodes 
(2) and the frequency of ssmDCs in PLNs is increased it is most 
likely that the ssmDCs and no other APC subset is responsible for 
the increased nTreg and Tml frequencies. The data are consistent 
with recent genetic evidence that expanded DC populations affect 
T cell homeostasis, increasing Tconv and Treg subsets and favor-
ing a tolerogenic environment (36). Together, there is evidence 
that nTreg could respond to antigen presented by DCs in the 
steady state.
Previous data including our own indicate that harmless 
soluble OVA antigen as provided by a subcutaneously implanted 
osmotic minipump (12, 13, 15) and cell-associated self-antigens 
as mimicked by keratinocyte-restricted OVA neo-self-antigen 
expression (K5-mOVA) (15) induced tolerance by de novo 
converting naive CD4+ T cells into Foxp3+ iTregs. We identified 
the Langerin+ ssmDCs subsets in PLNs to be responsible for the 
iTreg conversion while the specific roles of the two Langerin+ 
subsets LCs and CD103+ Langerin+ dDCs were not separated 
(15). Here, we found that CD103+ Langerin+ dDCs are not 
increased in their frequency in PLNs of RelBDCko mice and do not 
show an increased rate of iTreg conversion. In contrast, increased 
frequencies of epidermal LCs and CD103− Langerin− dDCs in 
PLNs of RelBDCko mice correlated with increased frequencies of 
activated and proliferating nTregs. In conclusion, these findings 
may point to a division of labor among ssmDCs. While CD103+ 
Langerin+ dDCs mediate iTreg conversion, CD103− Langerin− 
dDCs may control nTreg maintenance and pool size. The role 
of LCs in iTreg and nTreg homeostasis remains unclear by the 
analysis here and previous findings (15).
RelB appears to be uniformly expressed in ssmDCs and thus 
marks the partial maturation process (semimaturation) of DCs 
(9). Partial maturation of ssmDCs is required to express CCR7 
and enable their lymph node homing (11, 15). The induction of 
CCR7 expression in DCs seems to be linked to the upregulation 
of MHC II and costimulatory molecules by transcription factors 
IRF-4 and IRF-8 (17). RelB expression is upregulated in ssmDCs 
but is not a specific characteristic of tolerogenic DCs as proposed 
by others (10) and can exert immunogenic and tolerogenic func-
tion in DCs. RelB-deficient mice develop skin lesions similar to 
atopic dermatitis, pointing to a tolerogenic role for RelB in the 
skin and may be LCs (37). However, RelB expression and nuclear 
translocation can be further enhanced in DCs together with other 
NF-κB/Rel family members upon full maturation induced by 
pathogens or inflammation (15). Together, it appears that RelB/
p52 heterodimers as expressed in ssmDCs may control the func-
tions of tolerogenic DCs (15) or in lymphorganogenesis, whereas 
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formation of RelB/p50 or p65/p50 canonical dimers promotes 
inflammatory programs in DCs (38, 39). RelB/p50 heterodimers 
seem to be generally required for production pro-inflammatory 
cytokines (40).
The RelB+ expression in ssmDCs may not be decisive for 
their tolerogenicity or immunogenicity. Also, iDCs are able 
to induce T  cell anergy or to induce iTregs (4, 5). Critical for 
Foxp3 induction in naive T  cells as a key transcription factor 
for iTreg induction are TGF-β and retinoic acid that may be 
provided by DCs or their environment (3). The expression of 
surface LAP molecules that keep TGF-β trapped in its inactive 
form (15) until it is released by the DCs for iTreg induction by 
αvβ8 integrin activity was shown to play a critical role to prevent 
autoimmunity (41, 42). In contrast, while the conditions of sta-
bly Foxp3-expressing nTreg maintenance have been identified 
as IL-2 and TCR signals, the specific DC subsets and maturation 
stage as well as the anatomic site of their stimulation have not 
been clearly dissected. Our data provide evidence that specific 
ssmDC subsets differ in their roles of iTreg conversion and nTreg 
maintenance.
In conclusion, our data provide evidence for a role of RelB 
expression in ssmDCs to control their migration potential of LCs 
and Langerin− dDCs in PLNs. The increased frequencies of these 
two DC subsets in PLNs coincide with an increase in nTreg and 
IL-2+ Tml, suggesting a model where the migratory DCs transport 
and present self-antigens to both T cell subsets. In this concept, 
Tml cells might represent autoreactive CD4+ T cells expressing 
only low affinity TCRs. As a consequence, stimulation of such 
T cells by self-antigens presented on ssmDCs is not sufficient to 
initiate an autoimmune response but promotes the secretion of 
low levels of IL-2 to stimulate nTreg proliferation, thereby adjust-
ing the homeostatic pool of nTreg.
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